Profil
Elke Bestel worked as the Chief Medical Officer at PregLem SA from 2012 to 2015 and as the VP, Head-Drug Safety & Pharmacovigilance at ObsEva SA from 2019 to 2022.
Dr. Bestel holds a doctorate degree from the University of Gottingen.
Anciens postes connus de Elke Bestel
| Sociétés | Poste | Fin |
|---|---|---|
| OBSEVA SA | Chief Tech/Sci/R&D Officer | 15/07/2019 |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Chief Tech/Sci/R&D Officer | 01/08/2015 |
Formation de Elke Bestel
| University of Gottingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
